0000899243-21-034986.txt : 20210902 0000899243-21-034986.hdr.sgml : 20210902 20210902200029 ACCESSION NUMBER: 0000899243-21-034986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krehlik Carrie CENTRAL INDEX KEY: 0001823899 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 211234846 MAIL ADDRESS: STREET 1: 6015 COLTON BLVD CITY: OAKLAND STATE: CA ZIP: 94611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-01 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001823899 Krehlik Carrie C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Human Resources Officer Restricted Stock Units 2021-09-01 4 A 0 32240 0.00 A Common Stock 32240 32240 D Restricted Stock Units 2021-09-01 4 A 0 42400 0.00 A Common Stock 42400 42400 D Stock Option (Right to Buy) 29.85 2021-09-01 4 A 0 49600 0.00 A 2031-08-31 Common Stock 49600 49600 D Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in six semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer. The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer. The stock option vests with respect to 25% of the underlying shares on August 2, 2022 and in 12 equal quarterly installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer. /s/ Miguel Carrillo, as Attorney-in-Fact 2021-09-02